A new label free spiral sensor using impedance spectroscopy to characterize hepatocellular carcinoma in tissue and serum samples

Reda Abdelbaset,Sherif M. Shawky,Mohammed A. A. Abdullah,Omar E. Morsy,Yahia A. Yahia,Yehya H. Ghallab,Marwa Matboli,Yehea Ismail
DOI: https://doi.org/10.1038/s41598-024-63141-5
IF: 4.6
2024-06-09
Scientific Reports
Abstract:Hepatocellular carcinoma (HCC) stands as the most prevalent form of primary liver cancer, predominantly affecting patients with chronic liver diseases such as hepatitis B or C-induced cirrhosis. Diagnosis typically involves blood tests (assessing liver functions and HCC biomarkers), imaging procedures such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), and liver biopsies requiring the removal of liver tissue for laboratory analysis. However, these diagnostic methods either entail lengthy lab processes, require expensive imaging equipment, or involve invasive techniques like liver biopsies. Hence, there exists a crucial need for rapid, cost-effective, and noninvasive techniques to characterize HCC, whether in serum or tissue samples. In this study, we developed a spiral sensor implemented on a printed circuit board (PCB) technology that utilizes impedance spectroscopy and applied it to 24 tissues and sera samples as proof of concept. This newly devised circuit has successfully characterized HCC and normal tissue and serum samples. Utilizing the distinct dielectric properties between HCC cells and serum samples versus the normal samples across a specific frequency range, the differentiation between normal and HCC samples is achieved. Moreover, the sensor effectively characterizes two HCC grades and distinguishes cirrhotic/non-cirrhotic samples from tissue specimens. In addition, the sensor distinguishes cirrhotic/non-cirrhotic samples from serum specimens. This pioneering study introduces Electrical Impedance Spectroscopy (EIS) spiral sensor for diagnosing HCC and liver cirrhosis in clinical serum—an innovative, low-cost, rapid (< 2 min), and precise PCB-based technology without elaborate sample preparation, offering a novel non-labeled screening approach for disease staging and liver conditions.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper aims to address the issues in the diagnosis of hepatocellular carcinoma (HCC). Current diagnostic methods such as blood tests, imaging examinations (e.g., CT and MRI), and liver biopsy have drawbacks such as being time-consuming, costly, or highly invasive. Therefore, there is an urgent need for rapid, low-cost, and non-invasive techniques to characterize HCC. This paper develops a helical sensor based on printed circuit board (PCB) technology, utilizing impedance spectroscopy to detect HCC in tissue and serum samples. The sensor successfully distinguishes HCC from normal samples by analyzing the unique dielectric properties of HCC cells and normal cells at different frequencies, and it can differentiate between different grades of HCC as well as cirrhotic and non-cirrhotic samples. Additionally, the sensor exhibits similar capabilities in serum samples. This innovative technology provides a novel label-free screening method that is rapid (<2 minutes), accurate, and does not require complex sample preparation, for disease staging and liver condition detection.